NCT03476213

Brief Summary

This study compares manual total intravenous anesthesia (TIVA) and target-controll infusion (TCI) in reduction of awareness and dreaming, and the haemodynamical stability during operation. Half of patients will be anesthetized using manual TIVA and other half using TCI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
14mo left

Started Mar 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Mar 2018Jun 2027

First Submitted

Initial submission to the registry

March 9, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

March 16, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 23, 2018

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 15, 2025

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Expected
Last Updated

May 10, 2024

Status Verified

May 1, 2024

Enrollment Period

7.8 years

First QC Date

March 9, 2018

Last Update Submit

May 9, 2024

Conditions

Keywords

Anesthesia AwarenessDreaming in anesthesiaTotal intravenous anesthesiaTarget-controll infusion

Outcome Measures

Primary Outcomes (1)

  • reduction of awareness

    consciousness during operation

    5 hours

Secondary Outcomes (2)

  • reduction of haemodynamical instability

    5 hours

  • reduction of norepinephrine dose

    5 hours

Study Arms (2)

Group TCI

EXPERIMENTAL

induction and anesthesia will be held by using target-controll infusion

Procedure: Group TCI

Group TIVA

ACTIVE COMPARATOR

induction and anesthesia will be held by manual dosing of propofol and sufentanil

Procedure: Group TIVA

Interventions

Group TCIPROCEDURE

Induction and anesthesia will be done by using Gepth model for sufentanil and Schnider effect model for propofol. Anesthetics will be aplicated using infusion pump Agilia (Fresenius Kabi). Another titration will be according to target value of entropy between 40 and 60 and surgical pleth index below 35.

Group TCI
Group TIVAPROCEDURE

Induction of anesthesia will be done by titrating of propofol to the dose of 1.2 mg/kg and sufentanil 5-10 ug according to body weight, maintaining of anesthesia using continuous infusion of propofol 5 mg/ kg/hour and sufentanil 35 ug/hour to reach the target value of entropy between 40 and 60 and surgical pleth index below 35.

Group TIVA

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Glasgow Coma scale 15
  • ASA Physical Status Classification System I - III
  • planed surgery for brain tumor to 5 hours
  • postoperative awakening

You may not qualify if:

  • NYHA III, IV
  • abuse of stimulating drugs, grass, alcohol dependence
  • BMI over 40 in females and over 35 in men
  • propofol alergie
  • awake operations
  • postoperative arteficial ventilation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Hradec Kralove

Hradec Králové, 50005, Czechia

RECRUITING

MeSH Terms

Conditions

Intraoperative Awareness

Condition Hierarchy (Ancestors)

Intraoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Pavel Dostal, MD, Ph.D.

    University Hospital Hradec Kralove

    STUDY DIRECTOR

Central Study Contacts

Vlasta Dostalova, MD. Ph.D.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Group A will be anesthetized using TIVA, group B using TCI
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 9, 2018

First Posted

March 23, 2018

Study Start

March 16, 2018

Primary Completion

December 15, 2025

Study Completion (Estimated)

June 30, 2027

Last Updated

May 10, 2024

Record last verified: 2024-05

Locations